000 | 01079 a2200301 4500 | ||
---|---|---|---|
005 | 20250516065106.0 | ||
264 | 0 | _c20120320 | |
008 | 201203s 0 0 eng d | ||
022 | _a1744-8328 | ||
024 | 7 |
_a10.1586/era.11.171 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHubner, Richard A | |
245 | 0 | 0 |
_aSunitinib for advanced pancreatic neuroendocrine tumors. _h[electronic resource] |
260 |
_bExpert review of anticancer therapy _cDec 2011 |
||
300 |
_a1817-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xtherapeutic use |
650 | 0 | 4 |
_aNeuroendocrine Tumors _xdrug therapy |
650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
650 | 0 | 4 | _aSunitinib |
700 | 1 | _aValle, Juan W | |
773 | 0 |
_tExpert review of anticancer therapy _gvol. 11 _gno. 12 _gp. 1817-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1586/era.11.171 _zAvailable from publisher's website |
999 |
_c21343422 _d21343422 |